Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2026 | Long-term irAEs from checkpoint inhibitors in luminal breast cancer

Shigehira Saji, MD, PhD, Fukushima Medical University, Fukushima, Japan, discusses the potential drawbacks of immune checkpoint inhibitors in luminal breast cancer, including the requirement for lifelong hormone treatment in patients who develop immune-related adverse events (irAEs) such as hypothyroidism or adrenal insufficiency. Dr Saji highlights the need to distinguish between patients who require intensive treatment and those who can be managed with conventional treatment, emphasizing the importance of additional steps to make this distinction possible. This interview took place at the European Society for Medical Oncology (ESMO) 2026 Congress in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

Have to be, if we do an immune checkpoint inhibitor, patients have to have an IRA also, which is hypothyroidism or adrenal insufficiency. So this may cause the lifetime administration of additional hormone treatment. So it may cause some problem to the patient. So we need to distinguish the patients who need really intensive treatment or can be treated by conventional treatment...

Have to be, if we do an immune checkpoint inhibitor, patients have to have an IRA also, which is hypothyroidism or adrenal insufficiency. So this may cause the lifetime administration of additional hormone treatment. So it may cause some problem to the patient. So we need to distinguish the patients who need really intensive treatment or can be treated by conventional treatment. So it needs some more steps we require to make it possible.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.